ICCC logo

Immucell Corp


ICCC: ImmuCell Corp is engaged in the healthcare sector. The company operates in the development, acquisition, manufacture, and sale of products that improve the health and productivity of cows for the dairy and beef industries. The firm has developed products that provide immediate immunity to newborn dairy and beef cattle and is developing product line extensions of its existing products that address mastitis. Its lead product, First Defense, is manufactured to prevent scours in newborn calves. It has two segments Scours and Mastitis. The company generates the majority of its revenue from the United States.


Show ICCC Financials

Consumer Interest
SEC Filings

Recent trades of ICCC by members of U.S. Congress

Quiver Logo

No Congress Trading data for this ticker

Congress Trading Dashboard

Recently reported changes by institutional investors

Quarterly net insider trading by ICCC's directors and management

Quiver Logo

No recent Insider Trading for this ticker

Insider Trading Dashboard

Government lobbying spending instances

Quiver Logo

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard
U.S. Patents

New patents grants

  • Patent Title: Methods and systems of producing pharmaceutical grade lantibiotics Jul. 17, 2018
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard

Number of mentions of ICCC in WallStreetBets Daily Discussion


Recent insights relating to ICCC

CNBC Recommendations

Recent picks made for ICCC stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in ICCC

Corporate Flights

Flights by private jets registered to ICCC